KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 97 filers reported holding KRONOS BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,963,768 | -24.4% | 3,818,283 | 0.0% | 4.56% | +23.9% |
| Q2 2023 | $6,567,447 | +17.8% | 3,818,283 | 0.0% | 3.68% | +1.2% |
| Q1 2023 | $5,574,693 | -9.9% | 3,818,283 | 0.0% | 3.64% | +74.4% |
| Q4 2022 | $6,185,619 | -51.6% | 3,818,283 | 0.0% | 2.08% | -55.5% |
| Q3 2022 | $12,791,000 | -8.0% | 3,818,283 | 0.0% | 4.68% | +5.6% |
| Q2 2022 | $13,899,000 | -49.7% | 3,818,283 | 0.0% | 4.44% | -21.5% |
| Q1 2022 | $27,606,000 | -46.8% | 3,818,283 | 0.0% | 5.65% | -23.0% |
| Q4 2021 | $51,890,000 | -35.2% | 3,818,283 | 0.0% | 7.34% | -18.3% |
| Q3 2021 | $80,031,000 | -12.5% | 3,818,283 | 0.0% | 8.98% | -13.3% |
| Q2 2021 | $91,448,000 | -18.2% | 3,818,283 | 0.0% | 10.35% | -2.1% |
| Q1 2021 | $111,761,000 | -2.0% | 3,818,283 | 0.0% | 10.57% | -38.2% |
| Q4 2020 | $114,052,000 | – | 3,818,283 | – | 17.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |